Prevention of virus-induced type 1 diabetes with antibiotic therapy

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 3805-3814

  Hara, Naoko ^a   Alkanani, Aimon K ^a   Ir, Diana ^b   Robertson, Charles E ^c   Wagner, Brandie D ^d   Frank, Daniel N ^b,e   Zipri, Danny ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Global Health and Health Disparities   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 17; INTERLEUKIN 6; RNA 16S;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BIFIDOBACTERIUM; CLOSTRIDIUM; CONTROLLED STUDY; DIABETOGENESIS; DRUG EFFICACY; FECES CULTURE; FEMALE; GENE EXPRESSION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTESTINE FLORA; JEJUNUM; LATENT RAT PARVOVIRUS; LYMPH NODE; LYMPHOCYTE COUNT; MALE; NONHUMAN; PANCREAS ISLET DISEASE; PARVOVIRUS; PARVOVIRUS INFECTION; PEYER PATCH; PRIORITY JOURNAL; PROTECTION; PYROSEQUENCING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; UPREGULATION; VIRAL CLEARANCE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG COMBINATIONS; FEMALE; INFLAMMATION MEDIATORS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; PARVOVIRUS; PEYER'S PATCHES; RATS; RATS, INBRED LEW; SULFADOXINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

EID: 84867286012     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201257     Document Type: Article

References (57)

1. Gianani, R., and G. S. Eisenbarth. 2005. The stages of type 1A diabetes: 2005. Immunol. Rev. 204: 232-249. (Pubitemid 40460505)
2. Jun, H. S., and J. W. Yoon. 2001. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 44: 271-285. (Pubitemid 32234451)
3. Jun, H. S., and J. W. Yoon. 2003. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19: 8-31.
4. Soltesz, G., C. C. Patterson, and G. Dahlquist; EURODIAB Study Group. 2007. Worldwide childhood type 1 diabetes incidence - what can we learn from epidemiology? Pediatr. Diabetes 8(Suppl. 6): 6-14. (Pubitemid 47323762)
5. Chervonsky, A. 2009. Innate receptors and microbes in induction of autoimmunity. Curr. Opin. Immunol. 21: 641-647.
6. Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9: 313-323.
7. Cerf-Bensussan, N., and V. Gaboriau-Routhiau. 2010. The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol. 10: 735-744.
8. Vaahtovuo, J., E. Munukka, M. Korkeamäki, R. Luukkainen, and P. Toivanen. 2008. Fecal microbiota in early rheumatoid arthritis. J. Rheumatol. 35: 1500-1505.
9. Frank, D. N., A. L. St Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104: 13780-13785. (Pubitemid 350003397)
10. Sinkorová, Z., J. Capková, J. Niederlová, R. Stepánková, and J. Sinkora. 2008. Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum. Immunol. 69: 845-850.
11. Mathis, D., and C. Benoist. 2012. The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol. Rev. 245: 239-249.
12. Vaarala, O., M. A. Atkinson, and J. Neu. 2008. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
13. Giongo, A., K. A. Gano, D. B. Crabb, N. Mukherjee, L. L. Novelo, G. Casella, J. C. Drew, J. Ilonen, M. Knip, H. Hyoty, et al. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5: 82-91.
14. Wen, L., R. E. Ley, P. Y. Volchkov, P. B. Stranges, L. Avanesyan, A. C. Stonebraker, C. Hu, F. S. Wong, G. L. Szot, J. A. Bluestone, et al. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
15. Calcinaro, F., S. Dionisi, M. Marinaro, P. Candeloro, V. Bonato, S. Marzotti, R. B. Corneli, E. Ferretti, A. Gulino, F. Grasso, et al. 2005. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48: 1565-1575. (Pubitemid 41175510)
16. Matsuzaki, T., Y. Nagata, S. Kado, K. Uchida, I. Kato, S. Hashimoto, and T. Yokokura. 1997. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 105: 643-649. (Pubitemid 27380828)
17. Brugman, S., F. A. Klatter, J. T. Visser, A. C. Wildeboer-Veloo, H. J. Harmsen, J. Rozing, and N. A. Bos. 2006. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49: 2105-2108. (Pubitemid 44168478)
18. Roesch, L. F., G. L. Lorca, G. Casella, A. Giongo, A. Naranjo, A. M. Pionzio, N. Li, V. Mai, C. H. Wasserfall, D. Schatz, et al. 2009. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 3: 536-548.
19. Frank, D. N., W. Zhu, R. B. Sartor, and E. Li. 2011. Investigating the biological and clinical significance of human dysbioses. Trends Microbiol. 19: 427-434.
20. Lau, K., P. Benitez, A. Ardissone, T. D. Wilson, E. L. Collins, G. Lorca, N. Li, D. Sankar, C. Wasserfall, J. Neu, et al. 2011. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J. Immunol. 186: 3538-3546.
21. Kriegel, M. A., E. Sefik, J. A. Hill, H. J. Wu, C. Benoist, and D. Mathis. 2011. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 108: 11548-11553.
22. Zipris, D. 2010. Toll-like receptors and type 1 diabetes. Adv. Exp. Med. Biol. 654: 585-610.
23. Mordes, J. P., D. L. Guberski, J. H. Leif, B. A. Woda, J. F. Flanagan, D. L. Greiner, E. H. Kislauskis, and R. S. Tirabassi. 2005. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 54: 2727-2733. (Pubitemid 41233596)
24. Ellerman, K. E., C. A. Richards, D. L. Guberski, W. R. Shek, and A. A. Like. 1996. Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 45: 557-562. (Pubitemid 26140537)
25. Zipris, D. 2011. Innate immunity in type 1 diabetes. Diabetes Metab. Res. Rev. 27: 824-829.
26. Zipris, D., E. Lien, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini. 2005. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174: 131-142. (Pubitemid 40007399)
27. Zipris, D., E. Lien, A. Nair, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini. 2007. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J. Immunol. 178: 693-701. (Pubitemid 46095141)
28. Zipris, D. 2008. Innate immunity and its role in type 1 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 15: 326-331.
29. Wolter, T. R., R. Wong, S. A. Sarkar, and D. Zipris. 2009. DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced autoimmune diabetes. Clin. Immunol. 132: 103-115.
30. Zipris, D., J. L. Hillebrands, R. M. Welsh, J. Rozing, J. X. Xie, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2003. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J. Immunol. 170: 3592-3602. (Pubitemid 36359227)
31. Guberski, D. L., V. A. Thomas, W. R. Shek, A. A. Like, E. S. Handler, A. A. Rossini, J. E. Wallace, and R. M. Welsh. 1991. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254: 1010-1013. (Pubitemid 21917431)
32. Frank, D. N. 2008. XplorSeq: a software environment for integrated management and phylogenetic analysis of metagenomic sequence data. BMC Bioinformatics 9: 420.
33. Lane, D. J. 1991. 16S/23S rRNA sequencing. In Nucleic Acid Techniques in Bacterial Systematics. M. G. E. Stackebrandt, ed. Wiley, New York, p. 115-175.
34. Frank, D. N. 2009. BARCRAWL and BARTAB: software tools for the design and implementation of barcoded primers for highly multiplexed DNA sequencing. BMC Bioinformatics 10: 362.
35. Frank, D. N., L. M. Feazel, M. T. Bessesen, C. S. Price, E. N. Janoff, and N. R. Pace. 2010. The human nasal microbiota and Staphylococcus aureus carriage. PLoS ONE 5: e10598.
36. Nawrocki, E. P., D. L. Kolbe, and S. R. Eddy. 2009. Infernal 1.0: inference of RNA alignments. Bioinformatics 25: 1335-1337.
37. Cannone, J. J., S. Subramanian, M. N. Schnare, J. R. Collett, L. M. D'Souza, Y. Du, B. Feng, N. Lin, L. V. Madabusi, K. M. Müller, et al. 2002. The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs. BMC Bioinformatics 3: 2.
38. Haas, B. J., D. Gevers, A. M. Earl, M. Feldgarden, D. V. Ward, G. Giannoukos, D. Ciulla, D. Tabbaa, S. K. Highlander, E. Sodergren, et al Human Microbiome Consortium. 2011. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21: 494-504.
39. DeSantis, T. Z., Jr., P. Hugenholtz, K. Keller, E. L. Brodie, N. Larsen, Y. M. Piceno, R. Phan, and G. L. Andersen. 2006. NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res. 34(Web Server issue): W394-W399.
40. Wang, Q., G. M. Garrity, J. M. Tiedje, and J. R. Cole. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73: 5261-5267. (Pubitemid 47326658)
41. Magurran, A. E. 2004. Measuring Biological Diversity. Blackwell, Malden, MA.
42. Frank, J. A., C. I. Reich, S. Sharma, J. S. Weisbaum, B. A. Wilson, and G. J. Olsen. 2008. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl. Environ. Microbiol. 74: 2461-2470. (Pubitemid 351555459)
43. Valladares, R., D. Sankar, N. Li, E. Williams, K. K. Lai, A. S. Abdelgeliel, C. F. Gonzalez, C. H. Wasserfall, J. Larkin, D. Schatz, et al. 2010. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE 5: e10507.
44. Kohanski, M. A., D. J. Dwyer, and J. J. Collins. 2010. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8: 423-435.
45. Willing, B. P., S. L. Russell, and B. B. Finlay. 2011. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 9: 233-243.
46. Londono, P., A. Komura, N. Hara, and D. Zipris. 2010. Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetes. Clin. Immunol. 135: 401-411.
47. Nagano, Y., K. Itoh, and K. Honda. The induction of Treg cells by gut-indigenous Clostridium. Curr. Opin. Immunol. 24: 392-397.
48. Ball-Goodrich, L. J., F. X. Paturzo, E. A. Johnson, K. Steger, and R. O. Jacoby. 2002. Immune responses to the major capsid protein during parvovirus infection of rats. J. Virol. 76: 10044-10049. (Pubitemid 35006545)
49. Hirt, B. 2000. Molecular biology of autonomous parvoviruses. Contrib. Microbiol. 4: 163-177.
50. Ichinohe, T., I. K. Pang, Y. Kumamoto, D. R. Peaper, J. H. Ho, T. S. Murray, and A. Iwasaki. 2011. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. USA 108: 5354-5359.
51. Bamias, G., M. Marini, C. A. Moskaluk, M. Odashima, W. G. Ross, J. Rivera-Nieves, and F. Cominelli. 2002. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J. Immunol. 169: 5308-5314. (Pubitemid 35217204)
52. Eizirik, D. L., M. L. Colli, and F. Ortis. 2009. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5: 219-226.
53. Rath, H. C., M. Schultz, R. Freitag, L. A. Dieleman, F. Li, H. J. Linde, J. Schölmerich, and R. B. Sartor. 2001. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69: 2277-2285. (Pubitemid 32241818)
54. Elinav, E., T. Strowig, A. Kau, J. Henao-Mejia, C. Thaiss, C. Booth, D. Peaper, J. Bertin, S. Eisenbarth, J. Gordon, and R. Flavell. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
55. Maslowski, K. M., and C. R. Mackay. 2011. Diet, gut microbiota and immune responses. Nat. Immunol. 12: 5-9.
56. Kane, M., L. K. Case, K. Kopaskie, A. Kozlova, C. MacDearmid, A. V. Chervonsky, and T. V. Golovkina. 2011. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334: 245-249.
57. Kuss, S. K., G. T. Best, C. A. Etheredge, A. J. Pruijssers, J. M. Frierson, L. V. Hooper, T. S. Dermody, and J. K. Pfeiffer. 2011. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334: 249-252.